Antagonizing the innate pattern recognition receptor CD204 to improve dendritic cell-targeted cancer immunotherapy

OncoImmunology

Volumn 1, Issue 5, 2012, Pages 770-772

  Yu, Xiaofei ^a,b   Wang, Xiang Yang ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

CD204; Dendritic cells; Innate immune receptor; T cell response; Tumor immunity; Vaccine

Indexed keywords

CD204 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; PATTERN RECOGNITION RECEPTOR; SCAVENGER RECEPTOR; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; IMMUNOREGULATION; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUMOR IMMUNITY;

EID: 84886944336     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19728     Document Type: Article

References (10)

1. Wang XY, Facciponte JG, Subjeck JR. Molecular chaperones and cancer immunotherapy. Handb Exp Pharmacol 2006; 172:305-29; PMID:16610365; http://dx.doi.org/10.1007/3-540-29717-0_13
2. Wang XY, Facciponte J, Chen X, Subjeck JR, Repasky EA. Scavenger receptor-A negatively regulates antitumor immunity. Cancer Res 2007; 67:4996-5002; PMID: 17510431; http://dx.doi.org/10.1158/0008-5472.CAN-06-3138
3. Yi H, Yu X, Gao P, Wang Y, Baek SH, Chen X, et al. Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood 2009; 113:5819-28; PMID:19349620; http://dx.doi.org/10.1182/blood-2008-11-190033
4. Yu X, Yi H, Guo C, Zuo D, Wang Y, Kim HL, et al. Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6. J Biol Chem 2011; 286:18795-806; PMID:21460221; http://dx.doi.org/10.1074/jbc.M111.224345
5. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622
6. Qian J, Yi H, Guo C, Yu X, Zuo D, Chen X, et al. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma. J Immunol 2011; 187:2905-14; PMID:21832164; http://dx.doi.org/10.4049/jimmunol.1100703
7. Guo C, Yi H, Yu X, Hu F, Zuo D, Subjeck JR, et al. Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response. Immunol Cell Biol 2012; 90:101-8; PMID:21383767; http://dx.doi.org/10.1038/icb.2011.10
8. Yi H, Zuo D, Yu X, Hu F, Manjili MH, Chen Z, et al. Suppression of antigen-specific CD4(+) T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell. J Mol Med (Berl) 2011; PMID:22083206; http://dx.doi.org/10.1007/s00109-011-0828-1
9. Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, et al. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer Res 2011; 71:6611-20; PMID:21914786; http://dx.doi.org/10.1158/0008-5472.CAN-11-1801
10. Bak SP, Walters JJ, Takeya M, Conejo-Garcia JR, Berwin BL. Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. Cancer Res 2007; 67:4783-9; PMID:17510407; http://dx.doi.org/10.1158/0008-5472.CAN-06-4410